You are here » Home » Companies » Company Overview » Indoco Remedies Ltd

Indoco Remedies Ltd.

BSE: 532612 Sector: Health care
NSE: INDOCO ISIN Code: INE873D01024
BSE LIVE 15:40 | 25 Sep 208.20 6.15
(3.04%)
OPEN

198.20

HIGH

209.70

LOW

195.10

NSE 15:41 | 25 Sep 208.55 3.35
(1.63%)
OPEN

207.50

HIGH

209.90

LOW

196.70

OPEN 198.20
PREVIOUS CLOSE 202.05
VOLUME 2222
52-Week high 351.50
52-Week low 179.00
P/E 53.38
Mkt Cap.(Rs cr) 1,919
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00
OPEN 198.20
CLOSE 202.05
VOLUME 2222
52-Week high 351.50
52-Week low 179.00
P/E 53.38
Mkt Cap.(Rs cr) 1,919
Buy Price 0.00
Buy Qty 0.00
Sell Price 0.00
Sell Qty 0.00

Indoco Remedies Ltd. (INDOCO) - Company History

Indoco Remedies (Indoco) is a Mumbai-based pharmaceutical company that focuses on formulations, with some presence in contract manufacturing and research. It also trades some active pharma ingredients (APIs) manufactured by a group company. Currently, Indoco has a presence in the therapeutic segments including anti-infective, anti-cold preparation, opthalmic, anti-spasmodic, stomatology, anti-inflammatory and anti-fungal. As per AC Nielsen ORG-MARG market survey (August 2004) of doctors, Indoco ranked first in the stomatology, ninth in the opthalmic and twelve in the pediatric segments in terms of prescription generation in the domestic market. In the overall pharma industry, Indoco is ranked 34th as per AC Nielsen ORG-MARG Retail Audit, but ranked 23rd in terms of prescription generation, indicating the strength of its marketing network. Further, the company last year launched a new super specialty division, with focus on diabetic and cardio-vascular segments. Its entry into the lifestyle segment with a strong presence in the prescription segment would augur well for the higher- than-average industry growth. Currently, Indoco has four manufacturing facilities. Two are located in Mumbai and two in Goa, and an R&D centre in Mumbai. The solid dosage facility in Goa has been accredited by UK-Medicines and Healthcare Products Regulatory Agency (MHRA), and the sterile plant of Goa has been designed as per US Food and Drug Administration (FDA) norms. On the selling front, it has a marketing network of 1,248 medical representatives.